Skip to main content
. 2023 Feb 5;15(4):1012. doi: 10.3390/cancers15041012

Table 3.

Distribution of genes’ variation between cases and controls.

Groups by Genes n Df X 2 p
BCL2-938 C > A CC CA AA G A
Cases 100 37 (37%) 58 (58%) 5 (5%) 2 6.79 0.64 0.34 0.033
Controls 105 57 (54.28%) 42 (40%) 6 (5.71%) 0.74 0.26
MCL1-rs9803935 T > G TT GT GG T G
Cases 100 36 (36%) 54 (54%) 10 (10%) 2 6.03 0.63 0.37 0.049
Controls 105 58 (52.7%) 45 (40.9%) 07 (6.36%) 0.73 0.27
Survivin-rs17882312 G > C CC GC GG C G
Cases 100 31 (31%) 65 (65%) 04 (4%) 2 14.4 0.64 0.36 0.003
Controls 105 64 (58.1%) 45 (40.9%) 1 (0.90%) 0.79 0.21
Survivin-rs9904341 G > C GG GC CC G C
Cases 100 29 (29%) 66 (66%) 05 (5%) 2 18.4 0.62 0.38 0.001
Controls 105 70 (57%) 50 (40.9%) 02 (1.63%) 0.58 0.42